Blog · Evidence, in plain language

Insomnia treatment: what we tell patients about combining care.

When patients ask whether they need therapy for sleep, medicine for sleep, or both, we now have a guideline that compared those choices directly. The American Academy of Sleep Medicine published it in 2026. This is the summary we give, including the low certainty rating the panel gave its own evidence.

By Karel Winner, DNP, PMHNP-BC · Published October 13, 2026

This post is education from the practice, not medical advice. It summarizes a published guideline on insomnia treatment. It is not a recommendation about any individual's care.

The short answer

The 2026 guideline ranks the options. CBT-I, cognitive behavioral therapy for insomnia, on its own comes first. CBT-I combined with insomnia medication comes second, and the guideline suggests that combination over medication alone. Medication on its own comes last. Chronic insomnia disorder affects roughly 10 to 15 percent of adults, so this ranking touches a large share of the patients any psychiatry practice sees. Both recommendations are conditional, and the evidence behind them is rated low certainty, which means the panel expects individual circumstances and patient priorities to move the choice in a real share of cases.

What we are careful about

Each side of the comparison rested on six randomized trials reported in seven articles, a thin base for a common condition. Against medication alone, the combination improved insomnia severity and sleep continuity by meaningful but small amounts, with slightly more morning sleepiness reported. Against CBT-I alone, the combination added no meaningful gain in severity, continuity, or daytime symptoms. It did add total sleep time by an amount the panel counted as meaningful, though the confidence interval included zero. The guideline also covers only treatments started at the same time. Adding a second treatment later, which is common in real care, was barely studied and carries no recommendation.

How it fits care here

This practice offers therapy and medication management under one roof, so the guideline speaks directly to how we sequence a plan. We treat CBT-I as treatment in its own right, not as support for a prescription. Medication is added for a stated reason, reviewed at follow-up, and kept only while it is earning its place. The guideline's own exception fits that approach: a patient who values more total sleep early, perhaps because of a safety sensitive job or a run of very short nights, may reasonably choose the combination first. That is a decision made in the visit, with the trade-offs named, not a default applied to everyone.

Read more, by door

Each clinical site in this practice keeps its own blog, and each has written this topic for its own readers. For the combined therapy and medication perspective, psych.us has published should you combine CBT-I and sleep medicine, with the full comparison and the access questions. For the medication focused read, PsychMed Care has published CBT-I or sleep medicine, including what the ranking means at a medication visit. When reading has done all it can, the booking page is the next step.

Sources

The summary above rests on the sources below.

Buysse and colleagues, Journal of Clinical Sleep Medicine (2026): the American Academy of Sleep Medicine clinical practice guideline on combination treatment for chronic insomnia disorder in adults, based on a systematic review using the GRADE process, with the evidence search completed in June 2025. Journal of Clinical Sleep Medicine.

American Academy of Sleep Medicine (2026): the guideline at a glance summary, listing both recommendations and the exception the guideline itself sets out for patients who value more total sleep early in treatment. AASM guideline at a glance.

Edinger and colleagues, Journal of Clinical Sleep Medicine (2021): the earlier AASM guideline on behavioral and psychological treatments for chronic insomnia, which gave multicomponent CBT-I its strong recommendation. PubMed record.

Please read this part

This post is educational and does not create a treatment relationship. Published guidelines describe group averages and cannot predict how any one person will respond to CBT-I, medication, or both. Patients of this practice who are weighing a change should raise it at a visit. Nothing here is a reason to change a working treatment on your own, and this post gives no dosing information.

If you are having thoughts of harming yourself, help is available now: call or text 988, text HOME to 741741 for Crisis Text Line, or call the NAMI Helpline at 1-800-950-6264. This practice is not an emergency service. If someone is in immediate danger, call 911. The crisis page lists more options.